#Haematology #Oncology #Scotland #NHSScotland #multiplemyeloma #GSK #Blenrep #belantamabmafodotin #Blenrepcombination #lenalidomide #ScottishMedicinesConsortium #SMC #bortezomibanddexamethasone #BVd #SMCrecommendation #phase3data #DREAMM7study #progressionfreesurvival
zurl.co/ydmDa
zurl.co/ydmDa
Scotland approves new treatment option for multiple myeloma patients - PharmaTimes
Blenrep combination offers improved survival for those ineligible for lenalidomide
pharmatimes.com
October 15, 2025 at 9:02 AM
Everybody can reply
1 reposts
1 likes